Will HPV vaccination affect cervical cancer morbidity and mortality world-wide?
a Beth Israel Hospital, Harvard Medical School , Boston , MA , USA.
Rebecca
R
Luckett
b Brigham and Women's Hospital, Harvard Medical School , Boston , MA , USA.
Sarah
S
Feldman
D003362:Cost-Benefit Analysis; D005260:Female; D014943:Global Health; D006801:Humans; D009017:Morbidity; D030361:Papillomavirus Infections / Q000401:mortality / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000627:therapeutic use*; D002583:Uterine Cervical Neoplasms / Q000401:mortality / Q000517:prevention & control*; D014611:Vaccination
D053918:Papillomavirus Vaccines
HPV vaccine; cervical cancer; morbidity; mortality